Home/Filings/4/0001104659-19-023694
4//SEC Filing

SOFINNOVA CAPITAL VI FCPR 4

Accession 0001104659-19-023694

CIK 0001760542other

Filed

Apr 24, 8:00 PM ET

Accepted

Apr 25, 4:15 PM ET

Size

17.7 KB

Accession

0001104659-19-023694

Insider Transaction Report

Form 4
Period: 2019-04-23
Transactions
  • Conversion

    Common Stock

    2019-04-23+888,1663,606,712 total
  • Conversion

    Series B Preferred Stock

    2019-04-231,719,1890 total
    Common Stock (1,719,189 underlying)
  • Conversion

    Common Stock

    2019-04-23+916,901999,357 total
  • Conversion

    Common Stock

    2019-04-23+1,719,1892,718,546 total
  • Conversion

    Series A Preferred Stock

    2019-04-23916,9010 total
    Common Stock (916,901 underlying)
  • Conversion

    Series C Preferred Stock

    2019-04-23888,1660 total
    Common Stock (888,166 underlying)
  • Purchase

    Common Stock

    2019-04-23$14.00/sh+357,142$4,999,9883,963,854 total
Transactions
  • Conversion

    Common Stock

    2019-04-23+916,901999,357 total
  • Conversion

    Common Stock

    2019-04-23+888,1663,606,712 total
  • Conversion

    Series A Preferred Stock

    2019-04-23916,9010 total
    Common Stock (916,901 underlying)
  • Conversion

    Series C Preferred Stock

    2019-04-23888,1660 total
    Common Stock (888,166 underlying)
  • Conversion

    Common Stock

    2019-04-23+1,719,1892,718,546 total
  • Purchase

    Common Stock

    2019-04-23$14.00/sh+357,142$4,999,9883,963,854 total
  • Conversion

    Series B Preferred Stock

    2019-04-231,719,1890 total
    Common Stock (1,719,189 underlying)
Footnotes (2)
  • [F1]The preferred stock automatically converted into the Issuer's common stock on a one-for-one basis at the closing of the Issuer's initial public offering held on April 23, 2019 without payment or further consideration and had no expiration date.
  • [F2]Sofinnova Partners SAS is the managing company of Sofinnova Capital VI FCPR and disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein, if any.

Documents

1 file

Issuer

HOOKIPA Pharma Inc.

CIK 0001760542

Entity typeother
IncorporatedXX

Related Parties

1
  • filerCIK 0001441261

Filing Metadata

Form type
4
Filed
Apr 24, 8:00 PM ET
Accepted
Apr 25, 4:15 PM ET
Size
17.7 KB